Related Experiment Video
Updated: May 23, 2026

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
Published on: May 27, 2016
The Proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-mRNA
Jacqueline C Shultz1, Ngoc Vu, Michael D Shultz
1Department of Biochemistry and Molecular Biology, Virginia Commonwealth University-School of Medicine, Room 2-016, Sanger Hall, 1101 East Marshall Street, P.O. Box 980614, Richmond, VA 23298, USA.
Abstract:
Two splice variants derived from the Bcl-x gene via alternative 5' splice site selection (5'SS) are proapoptotic Bcl-x(s) and antiapoptotic Bcl-x(L). Previously, our laboratory showed that apoptotic signaling pathways regulated the alternative 5'SS selection via protein phosphatase-1 and de novo ceramide. In this study, we examined the elusive prosurvival signaling pathways that regulate the 5'SS selection of Bcl-x pre-mRNA in cancer cells. Taking a broad-based approach by using a number of small-molecule inhibitors of various mitogenic/survival pathways, we found that only treatment of non-small cell lung cancer (NSCLC) cell lines with the phosphoinositide 3-kinase (PI3K) inhibitor LY294002 (50 micromol/L) or the pan-protein kinase C (PKC) inhibitor Gö6983 (25 micromol/L) decreased the Bcl-x(L)/(s) mRNA ratio. Pan-PKC inhibitors that did not target the atypical PKCs, PKCι and PKCζ, had no effect on the Bcl-x(L)/(s) mRNA ratio. Additional studies showed that downregulation of the proto-oncogene, PKCι, in contrast to PKCζ, also resulted in a decrease in the Bcl-x(L)/(s) mRNA ratio. Furthermore, downregulation of PKCι correlated with a dramatic decrease in the expression of SAP155, an RNA trans-acting factor that regulates the 5'SS selection of Bcl-x pre-mRNA. Inhibition of the PI3K or atypical PKC pathway induced a dramatic loss of SAP155 complex formation at ceramide-responsive RNA cis-element 1. Finally, forced expression of Bcl-x(L) "rescued" the loss of cell survival induced by PKCι siRNA. In summary, the PI3K/PKCι regulates the alternative splicing of Bcl-x pre-mRNA with implications in the cell survival of NSCLC cells.
Insights
Prosurvival pathways regulate Bcl-x alternative splicing in non-small cell lung cancer (NSCLC). Phosphoinositide 3-kinase (PI3K) and protein kinase C iota (PKCι) signaling impact Bcl-x mRNA splicing and cell survival.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Signaling
Background:
- Alternative 5' splice site selection of Bcl-x pre-mRNA generates proapoptotic Bcl-x(s) and antiapoptotic Bcl-x(L) isoforms.
- Previous studies linked apoptotic pathways, protein phosphatase-1, and ceramide to Bcl-x alternative splicing.
- The prosurvival signaling pathways regulating Bcl-x alternative splicing in cancer remain largely elusive.
Purpose of the Study:
- To investigate the prosurvival signaling pathways that control the alternative 5' splice site selection of Bcl-x pre-mRNA in non-small cell lung cancer (NSCLC) cells.
- To elucidate the role of specific kinases, including phosphoinositide 3-kinase (PI3K) and protein kinase C (PKC) isoforms, in regulating Bcl-x splicing.
- To determine the impact of these signaling pathways on cancer cell survival.
Main Methods:
- Utilized small-molecule inhibitors targeting various mitogenic/survival pathways, including PI3K and PKC inhibitors.
- Employed RNA interference (siRNA) to downregulate specific PKC isoforms (PKCι and PKCζ).
- Assessed Bcl-x(L)/(s) mRNA ratios, expression of RNA trans-acting factors (SAP155), and protein complex formation.
Main Results:
- Inhibition of PI3K or pan-PKC (specifically targeting PKCι and PKCζ) decreased the Bcl-x(L)/(s) mRNA ratio in NSCLC cells.
- Downregulation of PKCι, but not PKCζ, reduced the Bcl-x(L)/(s) mRNA ratio and decreased SAP155 expression.
- PI3K or atypical PKC inhibition disrupted SAP155 complex formation at a specific RNA element, and forced Bcl-x(L) expression rescued PKCι siRNA-induced cell death.
Conclusions:
- The PI3K/PKCι signaling pathway regulates the alternative splicing of Bcl-x pre-mRNA.
- This regulation of Bcl-x alternative splicing by PI3K/PKCι has significant implications for the cell survival of non-small cell lung cancer cells.
- SAP155 acts as a crucial RNA trans-acting factor in this pathway, linking PI3K/PKCι signaling to Bcl-x splicing outcomes.
Related Concept Videos
RNA Splicing
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

